Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.3 USD
-2.53%
Market Closed
Updated:
May 15, 2024
Amphastar Pharmaceuticals Inc
Total Other Income
|
Amphastar Pharmaceuticals Inc
Total Other Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Total Other Income
-$3.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Amphastar Pharmaceuticals Inc's Total Other Income?
Total Other Income
-3.9m
USD
-3.9m
USD
Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Total Other Income amounts to -3.9m USD.
What is Amphastar Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
-21%
-21%
The average annual Total Other Income growth rates for Amphastar Pharmaceuticals Inc have been 16% over the past three years , -21% over the past five years .
You don't have any saved screeners yet
